Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers.
Buy
Sell